Featured Research

from universities, journals, and other organizations

Tests Begin Of Flu Vaccine Grown In Insect Cell Lines

Date:
October 28, 2004
Source:
University Of Rochester Medical Center
Summary:
Scientists are launching a research study to check the effectiveness of a new type of flu vaccine that is made differently than the conventional vaccine, which is grown in eggs. The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

Scientists are launching a research study to check the effectiveness of a new type of flu vaccine that is made differently than the conventional vaccine, which is grown in eggs. The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

The study of FluBlOk, made by Protein Sciences Corp. of Meriden, Ct., was initiated by flu expert John Treanor, M.D., professor of medicine and director of the Vaccine and Treatment Evaluation Unit at the University of Rochester Medical Center. The study will include a total of 400 to 500 adults ages 18 to 49 at three sites: Rochester, the University of Virginia, and Cincinnati Children's Hospital.

Since the 1940s the chicken has been at the center of flu vaccination efforts, because fertilized chicken eggs are used to grow the flu viruses used in vaccines. Each egg contains less than a teaspoonful of material that will ultimately become part of a vaccine. Because of the complexity and sheer size of the process – tens of millions of eggs must be produced, and vaccine material must be "harvested" from each – it's typically a six-month process to produce enough vaccine for the public, when everything goes well.

Using a cell line instead of eggs to produce the vaccine would likely slice one or two months off the production process, says Treanor. That could reduce costs and also give scientists and physicians more time each year before they decide on that year's vaccine makeup, giving them crucial time to watch the spread of flu of around the globe and concoct a vaccine. Producing biological products in insect cell lines is common; the hepatitis B vaccine, for instance, is produced by human cell lines, and scientists from Rochester have developed an experimental vaccine against human papilloma virus using an insect cell line.

Reduced costs might also make it possible to boost the dose that patients receive. Last year in a study of the same product in 399 elderly people, Treanor found that people who had received more vaccine made twice as many antibodies to ward off flu than healthy people who got the conventional vaccine.

The new study is only for healthy people ages 18 through 49 who will not be getting a flu shot otherwise. The study will not include anyone from high-risk groups, such as pregnant women, people with pulmonary disease, the elderly, or health care workers. Those people should be vaccinated with conventional vaccine, which is known to work; the current study is testing an experimental vaccine to see whether it's effective.


Story Source:

The above story is based on materials provided by University Of Rochester Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Rochester Medical Center. "Tests Begin Of Flu Vaccine Grown In Insect Cell Lines." ScienceDaily. ScienceDaily, 28 October 2004. <www.sciencedaily.com/releases/2004/10/041027144633.htm>.
University Of Rochester Medical Center. (2004, October 28). Tests Begin Of Flu Vaccine Grown In Insect Cell Lines. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2004/10/041027144633.htm
University Of Rochester Medical Center. "Tests Begin Of Flu Vaccine Grown In Insect Cell Lines." ScienceDaily. www.sciencedaily.com/releases/2004/10/041027144633.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins